Serum peptide signatures for pancreatic cancer based on mass spectrometry: a comparison to CA19-9 levels and routine imaging techniques.
about
Developments in FTICR-MS and Its Potential for Body Fluid SignaturesSolid-phase extraction strategies to surmount body fluid sample complexity in high-throughput mass spectrometry-based proteomicsApplication of a Serum Protein Signature for Pancreatic Cancer to Separate Cases from Controls in a Pancreatic Surveillance Cohort.
P2860
Serum peptide signatures for pancreatic cancer based on mass spectrometry: a comparison to CA19-9 levels and routine imaging techniques.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Serum peptide signatures for p ...... nd routine imaging techniques.
@ast
Serum peptide signatures for p ...... nd routine imaging techniques.
@en
type
label
Serum peptide signatures for p ...... nd routine imaging techniques.
@ast
Serum peptide signatures for p ...... nd routine imaging techniques.
@en
prefLabel
Serum peptide signatures for p ...... nd routine imaging techniques.
@ast
Serum peptide signatures for p ...... nd routine imaging techniques.
@en
P2093
P2860
P50
P1476
Serum peptide signatures for p ...... and routine imaging techniques
@en
P2093
André M Deelder
Anouck Huijbers
Bart J Mertens
Berit Velstra
Bert A Bonsing
Marieke A Vonk
Rob A E M Tollenaar
Wilma E Mesker
P2860
P2888
P304
P356
10.1007/S00432-014-1812-2
P577
2014-09-21T00:00:00Z